Tyra Biosciences 从机构投资者那里获得了 2 亿美元的私募融资，用于研发和运营。 Tyra Biosciences secured $200M private placement financing from institutional investors for R&D and operations.

Tyra Biosciences 宣布与机构和认可投资者达成 2 亿美元私募融资协议后，该公司股价大幅上涨。 Tyra Biosciences' stock rose significantly after the company announced a $200 million private placement financing agreement with institutional and accredited investors. 该生物技术公司计划将所得款项用于研发活动和其他运营目的。 The biotechnology firm plans to use the proceeds for research and development activities and other operational purposes. 本轮融资的知名投资者包括 RA Capital Management、Boxer Capital、BVF Partners、Nextech Invest Ltd、OrbiMed 和 5AM Ventures。 Notable investors in the financing round include RA Capital Management, Boxer Capital, BVF Partners, Nextech Invest Ltd, OrbiMed, and 5AM Ventures.